Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

S. R. Alberts, C. Erlichman, J. Sloan, S. H. Okuno, P. A. Burch, J. Rubin, H. C. Pitot, R. M. Goldherg, A. A. Adjei, P. J. Atherton, S. H. Kaufmann

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks'. Together they form a unique fingerprint.

Medicine & Life Sciences